Literature DB >> 2721500

Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas.

M L Breuer1, H T Cuypers, A Berns.   

Abstract

We have compared proviral integrations near (putative) proto-oncogenes in Moloney murine leukemia virus-induced primary and transplanted T cell lymphomas. We previously found proviruses integrated near c-myc, pim-1, and N-myc in primary tumors (Selten et al., 1984; Van Lohuizen et al., 1989a; Van Lohuizen et al., 1989b). We have now identified an additional common proviral integration site, called pim-2, that carries somatically acquired proviruses in the majority of transplanted tumors. In primary tumors integration near pim-2 is usually undetectable or present in only a minor fraction of the tumor cells. This subpopulation selectively grows out upon transplantation. Insertion near pim-2 is a relatively late event in tumorigenesis and is often preceded by proviral insertions in other common insertion sites, yielding tumor clones which carry proviruses in up to three different common insertion sites within the same cell (c-myc, pim-1 and pim-2). The data suggest that pim-2 plays an important role in tumor progression.

Entities:  

Mesh:

Year:  1989        PMID: 2721500      PMCID: PMC400870          DOI: 10.1002/j.1460-2075.1989.tb03434.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  23 in total

1.  Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes.

Authors:  H T Cuypers; G C Selten; M Zijlstra; R E de Goede; C J Melief; A J Berns
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

Review 2.  Evolution of tumours and the impact of molecular oncology.

Authors:  G Klein; E Klein
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

Review 3.  Conditioned tumorigenicity of activated oncogenes.

Authors:  G Klein; E Klein
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

4.  The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases.

Authors:  G Selten; H T Cuypers; W Boelens; E Robanus-Maandag; J Verbeek; J Domen; C van Beveren; A Berns
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

5.  Invasiveness of T-cell hybridomas in vitro and their metastatic potential in vivo.

Authors:  E Roos; G La Rivière; J G Collard; M J Stukart; P De Baetselier
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

6.  The multistep nature of cancer development.

Authors:  E Farber
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

7.  Genetic mapping of Pim-1 putative oncogene to mouse chromosome 17.

Authors:  J Hilkens; H T Cuypers; G Selten; V Kroezen; J Hilgers; A Berns
Journal:  Somat Cell Mol Genet       Date:  1986-01

8.  Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus.

Authors:  G Peters; A E Lee; C Dickson
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

9.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

10.  Concerted DNA rearrangements in Moloney murine leukemia virus-induced thymomas: a potential synergistic relationship in oncogenesis.

Authors:  P N Tsichlis; P G Strauss; M A Lohse
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

View more
  37 in total

1.  Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase.

Authors:  Kevin C Qian; Joey Studts; Lian Wang; Kevin Barringer; Anthony Kronkaitis; Charline Peng; Alistair Baptiste; Roger LaFrance; Sheenah Mische; Bennett Farmer
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-02

2.  Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway.

Authors:  Ke Ren; Wei Zhang; Yujun Shi; Jianping Gong
Journal:  Pathol Oncol Res       Date:  2009-10-12       Impact factor: 3.201

3.  Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.

Authors:  J Jonkers; H C Korswagen; D Acton; M Breuer; A Berns
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

4.  Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation.

Authors:  Guoping Deng; Yasuhiro Nagai; Yan Xiao; Zhiyuan Li; Shujia Dai; Takuya Ohtani; Alison Banham; Bin Li; Shiaw-Lin Wu; Wayne Hancock; Arabinda Samanta; Hongtao Zhang; Mark I Greene
Journal:  J Biol Chem       Date:  2015-05-18       Impact factor: 5.157

5.  Provirus insertion in Tpl-1, an Ets-1-related oncogene, is associated with tumor progression in Moloney murine leukemia virus-induced rat thymic lymphomas.

Authors:  S E Bear; A Bellacosa; P A Lazo; N A Jenkins; N G Copeland; C Hanson; G Levan; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.

Authors:  Ningfei An; Ying-Wei Lin; Sandeep Mahajan; Joshua N Kellner; Yong Wang; Zihai Li; Andrew S Kraft; Yubin Kang
Journal:  Stem Cells       Date:  2013-06       Impact factor: 6.277

7.  Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas.

Authors:  D Bergeron; L Poliquin; C A Kozak; E Rassart
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Authors:  Casey J Fox; Peter S Hammerman; Ryan M Cinalli; Stephen R Master; Lewis A Chodosh; Craig B Thompson
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

9.  AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.

Authors:  Erika K Keeton; Kristen McEachern; Keith S Dillman; Sangeetha Palakurthi; Yichen Cao; Michael R Grondine; Surinder Kaur; Suping Wang; Yuching Chen; Allan Wu; Minhui Shen; Francis D Gibbons; Michelle L Lamb; Xiaolan Zheng; Richard M Stone; Daniel J Deangelo; Leonidas C Platanias; Les A Dakin; Huawei Chen; Paul D Lyne; Dennis Huszar
Journal:  Blood       Date:  2013-12-20       Impact factor: 22.113

10.  Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.

Authors:  Alex N Bullock; Santina Russo; Ann Amos; Nicholas Pagano; Howard Bregman; Judit E Debreczeni; Wen Hwa Lee; Frank von Delft; Eric Meggers; Stefan Knapp
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.